Cabozantinib S Malate
9 Topics FoundCabozantinib, sold under the brand names Cometriq and Cabometyx among others, is a medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. It was discovered and developed by Exelixis Inc. In November 2012, cabozantinib in its capsule formulation was approved by the U.S. Food and Drug Administration (FDA) under the name Cometriq for treating ...
Cabozantinib S-malate by Catalent Pharma Solutions, LLC ## Markings: XL184;20mg XL184;80mg ## Shape: Capsule ## Active Ingredients: Cabozantinib S-malate
Cabozantinib S-malate by Catalent Pharma Solutions, LLC ## Markings: XL184;20mg XL184;80mg ## Shape: Capsule ## Active Ingredients: Cabozantinib S-malate
Cabozantinib S-malate by Catalent Pharma Solutions, LLC ## Markings: XL184;20mg ## Shape: Capsule ## Color: Gray ## Active Ingredients: Cabozantinib S-malate
4 {21 (Cabozantinib 20 mg Oral Capsule [cometriq]) } Pack [cometriq 60 mg Daily Dose Carton] by Exelixis, Inc. ## Markings: XL184;20mg ## Shape: Capsule ## Color: Gray ## Package Codes: 42388-013-14 ## Active Ingredients: Cabozantinib S-malate
Cometriq 20 mg Oral Capsule by Exelixis, Inc. ## Markings: XL184;20mg ## Shape: Capsule ## Color: Gray ## Package Codes: 42388-014-25 ## Active Ingredients: Cabozantinib S-malate
Cabometyx 20 mg Oral Tablet by Exelixis, Inc. ## Markings: XL;20 ## Shape: Round ## Color: Yellow ## Package Codes: 42388-024-26, 42388-024-37 ## Active Ingredients: Cabozantinib S-malate
Cabometyx 60 mg Oral Tablet by Exelixis, Inc. ## Markings: XL;60 ## Shape: Oval ## Color: Yellow ## Package Codes: 42388-023-26, 42388-023-36, 42388-023-37 ## Active Ingredients: Cabozantinib S-malate
Cabometyx 40 mg Oral Tablet by Exelixis, Inc. ## Markings: XL;40 ## Shape: Triangle (3 sides) ## Color: Yellow ## Package Codes: 42388-025-26, 42388-025-37 ## Active Ingredients: Cabozantinib S-malate